StonvexLoading…
StonvexStonvexStonvexCore line items from ORGO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $82.11M | $37.23M | $564.17M | $338.56M | $187.70M |
Operating Income | Not available | $-68.89M | $44.69M | $-18.59M | $-39.32M |
Net Income | Not available | $-53.16M | $37.03M | $-6.67M | $-28.23M |
EPS (Diluted) | $-0.11 | $-0.44 | $0.15 | $-0.12 | $-0.27 |
Total Assets | Not available | $519.99M | $598.73M | $509.83M | $461.13M |
Total Liabilities | Not available | $138.65M | $164.81M | $123.85M | $99.91M |
Cash & Equivalents | Not available | $91.38M | $93.68M | $63.74M | $73.08M |
Free Cash Flow OCF − CapEx | Not available | $17.98M | $-24.46M | $-59.23M | $-60.07M |
Shares Outstanding | Not available | 128.67M | 126.95M | 126.91M | 126.85M |